Literature DB >> 8632438

Synthesis and biological evaluation of N-acetylneuraminic acid-based rotavirus inhibitors.

M J Kiefel1, B Beisner, S Bennett, I D Holmes, M von Itzstein.   

Abstract

Rotavirus can cause severe gastrointestinal disease, especially in infants and young children, and is particularly prevalent in Third-World countries. Therefore, the development of potential inhibitors of this virus is of great interest. The present study describes the synthesis and in vitro biological evaluation of a number of N-acetylneuraminic acid-based compounds as potential rotavirus inhibitors. Our data suggests that it is indeed possible to inhibit adhesion of the virus, and hence in vitro replication, with carbohydrate-based molecules, although this inhibition does appear to be strain dependent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632438     DOI: 10.1021/jm950611f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Gerhard Wagner; Stephen C Harrison
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

2.  Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection.

Authors:  Fiona E Fleming; Raphael Böhm; Vi T Dang; Gavan Holloway; Thomas Haselhorst; Paul D Madge; Jaigeeth Deveryshetty; Xing Yu; Helen Blanchard; Mark von Itzstein; Barbara S Coulson
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

3.  How pure is your thiosialoside? A reinvestigation into the HPLC purification of thioglycosides of N-acetylneuraminic acid.

Authors:  D R Groves; S J Bradley; F J Rose; M J Kiefel; M von Itzstein
Journal:  Glycoconj J       Date:  1999-01       Impact factor: 2.916

4.  Protective efficacy of a sulfated sialyl lipid (NMSO3) against human rotavirus-induced diarrhea in a mouse model.

Authors:  Kazuo Takahashi; Kazutaka Ohashi; Yurika Abe; Shuichi Mori; Koki Taniguchi; Takusaburo Ebina; Osamu Nakagomi; Masaki Terada; Shiro Shigeta
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

5.  Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8* core.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Ola Blixt; James C Paulson; Gerhard Wagner; Stephen C Harrison
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Synthesis and evaluation of N-acetylneuraminic acid-based affinity matrices for the purification of sialic acid-recognizing proteins.

Authors:  S Ciccotosto; M J Kiefel; S Abo; W Stewart; K Quelch; M von Itzstein
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

Review 7.  Role of sialic acids in rotavirus infection.

Authors:  Pavel Isa; Carlos F Arias; Susana López
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

8.  O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia.

Authors:  Reshmi Parameswaran; Min Lim; Anna Arutyunyan; Hisham Abdel-Azim; Christian Hurtz; Kam Lau; Markus Müschen; Robert K Yu; Mark von Itzstein; Nora Heisterkamp; John Groffen
Journal:  J Exp Med       Date:  2013-03-11       Impact factor: 14.307

9.  Influenza C virus and bovine coronavirus esterase reveal a similar catalytic mechanism: new insights for drug discovery.

Authors:  Juliane Mayr; Thomas Haselhorst; Martijn A Langereis; Jeffrey C Dyason; Wolfgang Huber; Barbara Frey; Reinhard Vlasak; Raoul J de Groot; Mark von Itzstein
Journal:  Glycoconj J       Date:  2008-01-15       Impact factor: 2.916

10.  I, 5. Treatment of viral gastroenteritis.

Authors:  Dorsey Bass
Journal:  Perspect Med Virol       Date:  2004-09-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.